Vol. 58 No. 1 (2019): Acta Oncologica

Articles

• Increasing kidney cancer incidence and survival in Estonia: role of age and stage

  Kaire Innos, Teesi Sepp, Aleksei Baburin, Andres Kotsar, Katrin Lang, Peeter Padrik, Tiiu Aareleid

  21-28

  Published: 2019-01-02

  • PDF

• Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial

  Daniëlle B. P. Eekers, Erik Roelofs, Macarena Cubillos-Mesías, Charles Niël, Robert Jan Smeenk, Ann Hoeben, Andre W. H. Minken, Marlies Granzier, Geert O. Janssens, Johannes H. A. M. Kaanders, Philippe Lambin, Esther G. C. Troost

  57-65

  Published: 2019-01-02

  • PDF

• Comparative treatment planning study for mediastinal Hodgkin’s lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy

  Anneli Edvardsson, Malin Kügele, Sara Alkner, Marika Enmark, Joakim Nilsson, Ingrid Kristensen, Elisabeth Kjellén, Silke Engelholm, Sofie Ceberg

  95-104

  Published: 2019-01-02

  • PDF

• Imatinib mesylate in the management of chemotherapy-induced pulmonary toxicity: a double-edged sword

  Ahmet Emre Eskazan

  123-124

  Published: 2019-01-02

  • PDF

• The pioneers behind immune checkpoint blockers awarded the Nobel Prize in physiology or medicine 2018

  Olav Dahl, Marianne Brydøy

  1-8

  Published: 2019-01-02

  • PDF

• Breast cancer survival trends in different stages and age groups – a population-based study 1989–2013

  Anna E. Nordenskjöld, Helena. Fohlin, Lars G. Arnesson, Zakaria Einbeigi, Erik Holmberg, Per Albertsson, Per Karlsson

  45-51

  Published: 2019-01-02

  • PDF

• Automatic segmentation of cardiac substructures from noncontrast CT images: accurate enough for dosimetric analysis?

  Yangkun Luo, Yujin Xu, Zhongxing Liao, Daniel Gomez, Jingqian Wang, Wei Jiang, Rongrong Zhou, Ryan Williamson, Laurence E. Court, Jinzhong Yang

  81-87

  Published: 2019-01-02

  • PDF

• Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients

  Anne Sofie Brems-Eskildsen, Kristina Bak Kristoffersen, Søren Linnet, Tamás Lörincz, Sven Tyge Langkjer

  119-121

  Published: 2019-01-02

  • PDF

• Radiobiological issues in proton therapy

  Radhe Mohan, Christopher R. Peeler, Fada Guan, Lawrence Bronk, Wenhua Cao, David R. Grosshans

  132

  Published: 2019-01-02

  • PDF

• Occupational variation in bladder cancer in Nordic males adjusted with approximated smoking prevalence

  Kishor Hadkhale, Jan Ivar Martinsen, Elisabete Weiderpass, Kristina Kjærheim, Pär Sparén, Laufey Tryggvadóttir, Elsebeth Lynge, Eero Pukkala

  29-37

  Published: 2019-01-02

  • PDF

• National practice patterns of proton versus photon therapy in the treatment of adult patients with primary brain tumors in the United States

  Jeffrey M. Ryckman, Vaishnavi Ganesan, Adams Kusi Appiah, Chi Zhang, Vivek Verma

  66-73

  Published: 2019-01-02

  • PDF

• Heart sparing breast cancer radiotherapy using continuous positive airway pressure (CPAP) and conventional supine tangential fields: an alternative method for patients with limited accessibility to advanced radiotherapy techniques

  Whoon Jong Kil, Tabitha Pham, Kyubo Kim

  105-109

  Published: 2023-10-26

  • PDF

• Pazopanib in relapsed osteosarcoma patients: report on 15 cases

  Alessandra Longhi, Anna Paioli, Emanuela Palmerini, Marilena Cesari, Massimo E. Abate, Elisabetta Setola, Paolo Spinnato, Davide Donati, Ivar Hompland, Kjetil Boye

  124-128

  Published: 2019-01-02

  • PDF

• Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment

  Olav Dahl, Jon Espen Dale, Marianne Brydøy

  9-20

  Published: 2019-01-02

  • PDF

• Subsequent risk of cancer among women with a history of placental abruption

  Outi Riihimäki, Minna Tikkanen, Johanna Melin, Sture Andersson, Marjo Metsäranta, Mika Nuutila, Mika Gissler, Jorma Paavonen, Eero Pukkala

  52-56

  Published: 2019-01-02

  • PDF

• Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data

  D. Wegener, D. Zips, D. Thorwarth, J. Weiß, A. E. Othman, U. Grosse, M. Notohamiprodjo, K. Nikolaou, A. C. Müller

  88-94

  Published: 2019-01-02

  • PDF

• Antineoplastic treatment with crizotinib during pregnancy: a case report

  Kristian H. Jensen, Gitte Persson, Lone Storgaard, Birgitte B. Nielsen, Berit W. Pedersen, Lisa L. Maroun, Alwin Huitema, Mette Pøhl

  121-122

  Published: 2019-01-02

  • PDF

• Malignant pleural mesothelioma in Finland: regional and gender variation

  Sanna Laaksonen, Ilkka Ilonen, Eeva Kuosma, Eva Sutinen, Henrik Wolff, Tapio Vehmas, Kirsti Husgafvel-Pursiainen, Jarmo A. Salo, Katri Koli, Jari Räsänen, Marjukka Myllärniemi

  38-44

  Published: 2019-01-02

  • PDF

• Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy

  Aman Sharma, Marloes Duijm, Esther Oomen-de Hoop, Joachim G. Aerts, Cornelis Verhoef, Mischa Hoogeman, Joost Jan Nuyttens

  74-80

  Published: 2019-01-02

  • PDF

• Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study

  Frederik Birkebæk Thomsen, Cecilia Bosco, Hans Garmo, Jan Adolfsson, Niklas Hammar, Pär Stattin, Mieke Van Hemelrijck

  110-118

  Published: 2019-01-02

  • PDF

• Bone sarcoma during pregnancy: an example of personalized multidisciplinary care

  Marije Weidema, Suzanne Kaal, Loek de Jong, Nielka van Erp, Rosemarie Jansen, Bart Schreuder, Wieteke Heidema, Winette van der Graaf, Ingrid Desar

  128-131

  Published: 2019-01-02

  • PDF